logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (vi) Percentage distribution of new inpatient clients by primary drug for age at first use

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates13.137.85956.149.143.839.831.62706135
Cocaine1.856.47.910.48.562.635731
Stimulants16.623.114.310.49.15.99.63.4116683
Hypnotics and sedatives2.92.53.87.912.31727.746.234458
Hallucinogens1.21.510.50.3000758
Volatile substances13.43.310.400002498
Cannabis 5025.813.715.217.620.913.38.5166294
Other substances 10.90.81.61.33.93.67.78070
Total100729731430558318153831176639487

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008